143 related articles for article (PubMed ID: 36063598)
1. VSIG4-expressing tumor-associated macrophages impair anti-tumor immunity.
Jung K; Jeon YK; Jeong DH; Byun JM; Bogen B; Choi I
Biochem Biophys Res Commun; 2022 Nov; 628():18-24. PubMed ID: 36063598
[TBL] [Abstract][Full Text] [Related]
2. Antibodies Targeting Human or Mouse VSIG4 Repolarize Tumor-Associated Macrophages Providing the Potential of Potent and Specific Clinical Anti-Tumor Response Induced across Multiple Cancer Types.
Sazinsky S; Zafari M; Klebanov B; Ritter J; Nguyen PA; Phennicie RT; Wahle J; Kauffman KJ; Razlog M; Manfra D; Feldman I; Novobrantseva T
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892347
[TBL] [Abstract][Full Text] [Related]
3. Costimulatory molecule VSIG4 exclusively expressed on macrophages alleviates renal tubulointerstitial injury in VSIG4 KO mice.
Li Y; Wang YQ; Wang DH; Hou WP; Zhang Y; Li M; Li FR; Mu J; Du X; Pang F; Yuan FH
J Nephrol; 2014 Feb; 27(1):29-36. PubMed ID: 24424721
[TBL] [Abstract][Full Text] [Related]
4. VSIG4, a B7 family-related protein, is a negative regulator of T cell activation.
Vogt L; Schmitz N; Kurrer MO; Bauer M; Hinton HI; Behnke S; Gatto D; Sebbel P; Beerli RR; Sonderegger I; Kopf M; Saudan P; Bachmann MF
J Clin Invest; 2006 Oct; 116(10):2817-26. PubMed ID: 17016562
[TBL] [Abstract][Full Text] [Related]
5. Endogenous VSIG4 negatively regulates the helper T cell-mediated antibody response.
Jung K; Seo SK; Choi I
Immunol Lett; 2015 Jun; 165(2):78-83. PubMed ID: 25929804
[TBL] [Abstract][Full Text] [Related]
6. Protective role of V-set and immunoglobulin domain-containing 4 expressed on kupffer cells during immune-mediated liver injury by inducing tolerance of liver T- and natural killer T-cells.
Jung K; Kang M; Park C; Hyun Choi Y; Jeon Y; Park SH; Seo SK; Jin D; Choi I
Hepatology; 2012 Nov; 56(5):1838-48. PubMed ID: 22711680
[TBL] [Abstract][Full Text] [Related]
7. VSIG4 expression on macrophages facilitates lung cancer development.
Liao Y; Guo S; Chen Y; Cao D; Xu H; Yang C; Fei L; Ni B; Ruan Z
Lab Invest; 2014 Jul; 94(7):706-15. PubMed ID: 24862966
[TBL] [Abstract][Full Text] [Related]
8. VISTA Stimulation of VSIG4-Positive Macrophages Strongly Suppresses T Cell Proliferation via Excessive Nitric Oxide Production in Sepsis.
Lee SW
Biol Pharm Bull; 2021 Nov; 44(11):1645-1652. PubMed ID: 34433706
[TBL] [Abstract][Full Text] [Related]
9. VSIG4 alleviates intracerebral hemorrhage induced brain injury by suppressing TLR4-regulated inflammatory response.
Zhang D; Shen X; Pang K; Yang Z; Yu A
Brain Res Bull; 2021 Nov; 176():67-75. PubMed ID: 34419512
[TBL] [Abstract][Full Text] [Related]
10. IL2RA
Pan Z; Bao L; Lu X; Hu X; Li L; Chen J; Jin T; Zhang Y; Tan Z; Huang P; Ge M
Biochim Biophys Acta Mol Basis Dis; 2023 Jan; 1869(1):166591. PubMed ID: 36328145
[TBL] [Abstract][Full Text] [Related]
11. Identification and Functional Analysis of EPOR
Li Y; Li M; Wei R; Wu J
J Immunol Res; 2020; 2020():9374240. PubMed ID: 32908942
[TBL] [Abstract][Full Text] [Related]
12. The biology of VSIG4: Implications for the treatment of immune-mediated inflammatory diseases and cancer.
Liu B; Cheng L; Gao H; Zhang J; Dong Y; Gao W; Yuan S; Gong T; Huang W
Cancer Lett; 2023 Jan; 553():215996. PubMed ID: 36343787
[TBL] [Abstract][Full Text] [Related]
13. Extracellular stimulation of VSIG4/complement receptor Ig suppresses intracellular bacterial infection by inducing autophagy.
Kim KH; Choi BK; Kim YH; Han C; Oh HS; Lee DG; Kwon BS
Autophagy; 2016 Sep; 12(9):1647-59. PubMed ID: 27440002
[TBL] [Abstract][Full Text] [Related]
14. Possible role of arginase-1 in concomitant tumor immunity.
Korrer MJ; Zhang Y; Routes JM
PLoS One; 2014; 9(3):e91370. PubMed ID: 24614600
[TBL] [Abstract][Full Text] [Related]
15. Immune checkpoint protein VSIG4 as a biomarker of aging in murine adipose tissue.
Hall BM; Gleiberman AS; Strom E; Krasnov PA; Frescas D; Vujcic S; Leontieva OV; Antoch MP; Kogan V; Koman IE; Zhu Y; Tchkonia T; Kirkland JL; Chernova OB; Gudkov AV
Aging Cell; 2020 Oct; 19(10):e13219. PubMed ID: 32856419
[TBL] [Abstract][Full Text] [Related]
16. TFEB is a master regulator of tumor-associated macrophages in breast cancer.
Li Y; Hodge J; Liu Q; Wang J; Wang Y; Evans TD; Altomare D; Yao Y; Murphy EA; Razani B; Fan D
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32487570
[TBL] [Abstract][Full Text] [Related]
17. Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
Li G; Liu D; Kimchi ET; Kaifi JT; Qi X; Manjunath Y; Liu X; Deering T; Avella DM; Fox T; Rockey DC; Schell TD; Kester M; Staveley-O'Carroll KF
Gastroenterology; 2018 Mar; 154(4):1024-1036.e9. PubMed ID: 29408569
[TBL] [Abstract][Full Text] [Related]
18. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.
La Fleur L; Botling J; He F; Pelicano C; Zhou C; He C; Palano G; Mezheyeuski A; Micke P; Ravetch JV; Karlsson MCI; Sarhan D
Cancer Res; 2021 Feb; 81(4):956-967. PubMed ID: 33293426
[TBL] [Abstract][Full Text] [Related]
19. VSIG4/CRIg directly regulates early CD8
Widyagarini A; Nishii N; Kawano Y; Zhang C; Azuma M
Biochem Biophys Res Commun; 2022 Jul; 614():100-106. PubMed ID: 35576680
[TBL] [Abstract][Full Text] [Related]
20. BRD4 Inhibition by AZD5153 Promotes Antitumor Immunity via Depolarizing M2 Macrophages.
Li X; Fu Y; Yang B; Guo E; Wu Y; Huang J; Zhang X; Xiao R; Li K; Wang B; Hu J; Sun C; Chen G
Front Immunol; 2020; 11():89. PubMed ID: 32184777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
